[1]夭志刚,周念,严兵,等.小儿Xp11.2易位/TFE3基因融合相关性肾癌一例[J].临床小儿外科杂志,2020,19(02):189-190.[doi:10.3969/j.issn.1671-6353.2020.02.020]
点击复制

小儿Xp11.2易位/TFE3基因融合相关性肾癌一例

参考文献/References:

1 He J,Chen X,Gan W,et al.Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions:clinical experience and literature review[J].Future Oncol,2015,11(24):3243-3252.DOI:10.2217/fon.15.177.
2 Liu C,Zhang W,Song H.Nephron-sparing surgery in the treatment of pediatric renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions[J].J Pediatr Surg,2017,52(9):1492-1495.DOI:10.1016/j.jpedsurg.2017.03.052.
3 He J,Zhou B,Zhu B,et al.Dynamic contrast-enhanced CT characterization of Xp11.2 translocation/TFE3 gene fusions versus papillary renal cell carcinomas[J].Biomed Res Int,2015,2015:298679.DOI:10.1155/2015/298679.
4 AI-Maqhrabi JA,Khabaz MN.Uncommon localization of extrarenal Xp11.2 translocation-associated renal cell carcinoma (RCC):case report[J].Applied immunohistochemistry & molecular morphology:AIMM 2017.DOI:10.1097/ PAI.0000000000000576.
5 Choo MS,Jeonq CW,Song C,et al.Clinicopathologic characteristics and prognosis of Xp11.2 translocation renal cell carcinoma:multicenter,propensity score matching analysis[J].Clin Genitourin Cancer,2017,15(5):e819-e825.DOI:10.1016/j.clgc.2017.04.015.
6 Dey B,Badhe B,Govindarajan KK,et al.Xp11.2 translocation renal cell carcinoma diagnosed by immunohistochemistry and cytogenetics[J].J Lab Physicians,2016,8(2):123-125.DOI:10.4103/0974-2727.180796.
7 Hirobe M,Masumori N,Tanaka T,et al.Clinicopathological characteristics of Xp11.2 translocation renal cell carcinoma in adolescents and adults:Diagnosis using immunostaining of transcription factor E3 and fluorescence in situ hybridization analysis[J].Int J Urol,2016,23(2):140-145.DOI:10.1111/iju.13007.
8 Manucha V,Sessums MT,Lewin J,et al.Cyto-histological correlation of Xp11.2 translocation/TFE3 gene fusion associated renal cell carcinoma:Report of a case with review of literature[J].Diagn Cytopathol,2018,46(3);267-270.DOI:10.1002/dc.23839.
9 Bambury RM,Battley JE,McCarthy A,et al.Translocation Renal Cell Carcinomas:An Evolving Entity and a Member of the Microphthalmia Transcription Factor-Associated Family of Tumors[J].Clin Genitourin Cancer,2013,11(3):357-361.DOI:10.1016/j.clgc.2012.12.006.
10 Liu N,Gan W,Qu F,et al.Does the Fuhrman or World Health Organization/International Society of Urological Pathology Grading System apply to the xp11.2 translocation renal cell carcinoma:a 10-year single-center study[J].Am J Pathol,2018,188(4):929-936.DOI:10.1016/j.ajpath.2017.12.018.
11 井颖, 顾涛,王建林,等.小儿Xp11.2易位/TFE3基因融合相关性肾癌1例[J].临床小儿外科杂志,2015,14(2):157-160.DOI:10.3969/J.issn.1671-6353.2015.02.024. Jing Y,Gu T,Wang JL,et al.One case of renal carcinoma with Xp11.2 gene translocation/TFE3 gene fusion[J].J Clin Ped Sur,2015,14(2):157-160.DOI:10.3969/J.issn.1671-6353.2015.02.024.

备注/Memo

收稿日期:2018-04-10。
基金项目:云南省儿童重大疾病研究重点实验室(云科规[2018]号)
通讯作者:严兵,Email:yanbing@etyy.cn

更新日期/Last Update: 1900-01-01